165 related articles for article (PubMed ID: 16132504)
21. Gastrointestinal Kaposi's sarcoma: CD117 expression and the potential for misdiagnosis as gastrointestinal stromal tumour.
Parfitt JR; Rodriguez-Justo M; Feakins R; Novelli MR
Histopathology; 2008 Jun; 52(7):816-23. PubMed ID: 18494611
[TBL] [Abstract][Full Text] [Related]
22. [Gastrointestinal stromal tumor: a clinicopathological study of 74 cases].
Yang QC; Ji XH; Shen Y; Han F; Zhang XJ; Liu HB
Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):6-10. PubMed ID: 15796874
[TBL] [Abstract][Full Text] [Related]
23. Gastrointestinal stromal tumors presenting as pelvic masses: report of two cases.
Erkanli S; Kayaselcuk F; Törer N; Bolat F; Tarim E; Simsek E; Kuscu E
Eur J Gynaecol Oncol; 2006; 27(1):101-3. PubMed ID: 16550984
[TBL] [Abstract][Full Text] [Related]
24. [Differential diagnosis and treatment of esophageal stromal tumors and smooth muscle tumors].
Zhang X; Rong TH; Wu QL; Fu JH; Long H; Zhang LJ; Ma GW; Su XD; Li XD; Wang DF; Hu Y; Yang H
Ai Zheng; 2006 Jul; 25(7):901-5. PubMed ID: 16831287
[TBL] [Abstract][Full Text] [Related]
25. Gastro-intestinal stromal tumour--role of CD117 in diagnosis and management.
Paul PC; Chakraborty J; Kundu D; Sarkar R
Indian J Pathol Microbiol; 2007 Apr; 50(2):279-83. PubMed ID: 17883045
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117 (KIT).
Miettinen M; Sobin LH; Sarlomo-Rikala M
Mod Pathol; 2000 Oct; 13(10):1134-42. PubMed ID: 11048809
[TBL] [Abstract][Full Text] [Related]
27. C-KIT and PDGFRA zygosity in gastrointestinal stromal tumors: Correlation with tumor site, tumor size, exon, and CD117 immunohistochemistry.
Wallander ML; Willmore-Payne C; Layfield LJ
Appl Immunohistochem Mol Morphol; 2011 Jan; 19(1):21-7. PubMed ID: 20823768
[TBL] [Abstract][Full Text] [Related]
28. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases.
Miettinen M; Wang ZF; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1401-8. PubMed ID: 19606013
[TBL] [Abstract][Full Text] [Related]
29. CD117 (KIT) is a useful immunohistochemical marker for differentiating porocarcinoma from squamous cell carcinoma.
Goto K; Takai T; Fukumoto T; Anan T; Kimura T; Ansai S; Oshitani Y; Murata Y; Sakuma T; Hirose T
J Cutan Pathol; 2016 Mar; 43(3):219-26. PubMed ID: 26449497
[TBL] [Abstract][Full Text] [Related]
30. Gastrointestinal stromal tumors. A multicenter experience.
Urbańczyk K; Limon J; Korobowicz E; Chosia M; Sygut J; Karcz D; Iwanik K; Osuch C; Lasota J; Stachura J
Pol J Pathol; 2005; 56(2):51-61. PubMed ID: 16092666
[TBL] [Abstract][Full Text] [Related]
31. The significance of KIT (CD117) in gastrointestinal stromal tumors.
Hornick JL; Fletcher CD
Int J Surg Pathol; 2004 Apr; 12(2):93-7. PubMed ID: 15173913
[No Abstract] [Full Text] [Related]
32. [Status and clinical implication of c-kit and PDGFRA mutations in 165 cases of gastrointestinal stromal tumor (GIST)].
He HY; Fang WG; Zhong HH; Li Y; Zheng J; Du J; Heng WJ; Wu BQ
Zhonghua Bing Li Xue Za Zhi; 2006 May; 35(5):262-6. PubMed ID: 16776995
[TBL] [Abstract][Full Text] [Related]
33. Molecular alterations of KIT oncogene in gliomas.
Gomes AL; Reis-Filho JS; Lopes JM; Martinho O; Lambros MB; Martins A; Schmitt F; Pardal F; Reis RM
Cell Oncol; 2007; 29(5):399-408. PubMed ID: 17726262
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of miR-221 and miR-222 correlates with pronounced Kit expression in gastrointestinal stromal tumors.
Koelz M; Lense J; Wrba F; Scheffler M; Dienes HP; Odenthal M
Int J Oncol; 2011 Feb; 38(2):503-11. PubMed ID: 21132270
[TBL] [Abstract][Full Text] [Related]
35. Two novel cell specific receptor proteins, CRLR and CD 117 in human glial tumors.
Mennel HD; Hallier-Neelsen M; Hagner S; Benes L
Clin Neuropathol; 2006; 25(3):107-14. PubMed ID: 16719406
[TBL] [Abstract][Full Text] [Related]
36. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: the experience at 3 large medical centers in Mexico.
Alvarado-Cabrero I; Vázquez G; Sierra Santiesteban FI; Hernández-Hernández DM; Pompa AZ
Ann Diagn Pathol; 2007 Feb; 11(1):39-45. PubMed ID: 17240306
[TBL] [Abstract][Full Text] [Related]
38. Role and mechanism of vasculogenic mimicry in gastrointestinal stromal tumors.
Sun B; Qie S; Zhang S; Sun T; Zhao X; Gao S; Ni C; Wang X; Liu Y; Zhang L
Hum Pathol; 2008 Mar; 39(3):444-51. PubMed ID: 18261629
[TBL] [Abstract][Full Text] [Related]
39. MCQs for "Analysis of clinicopathological and immunohistochemical parameters and correlation of outcomes in gastrointestinal stromal tumors".
Darling HS; Jayalakshmi S; Jaiswal P
Indian J Cancer; 2019; 56(2):144-145. PubMed ID: 31062733
[No Abstract] [Full Text] [Related]
40. KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance.
Zhu MJ; Ou WB; Fletcher CD; Cohen PS; Demetri GD; Fletcher JA
Oncogene; 2007 Sep; 26(44):6386-95. PubMed ID: 17452978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
